Drug intelligence / Profile preview

EnFix TAC-T

Development stage
Unknown
Lead developer
Tetrous
Administration
Implant
01

Overview

EnFix TAC-T is a demineralized bone fiber (DBF) allograft implant developed by Tetrous, Inc. for use in orthopedic soft tissue repairs, primarily rotator cuff repair surgery. Derived from 100% demineralized cortical bone allograft from voluntarily donated human tissues, EnFix TAC-T is classified as a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) under FDA 21 CFR Part 1271. The implant is designed to enhance biologic healing at the bone-to-tendon interface (the enthesis) by exposing bone morphogenetic proteins (BMPs) and other growth factors that stimulate osteoinductive and osteoconductive tissue formation. EnFix TAC-T features a cannulated design that allows bone marrow elements to wick up from the subchondral bone into the healing site, and is configured specifically to accommodate varying bone availability based on rotator cuff tear size. It can be used independently of a suture anchor or in conjunction with all-suture anchors.

Brand names
EnFix TAC-T
Other names
EnFixEnFix TAC
02

Targets

SMAD (SMAD family)BMPR (Bone morphogenetic protein receptor)

Beyond the preview

Go deeper on EnFix TAC-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnFix TAC-T.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call